Quick Read
-
SCHD’s concentration in its top 10 stocks stands at 41%, surpassing the S&P 500’s 36%, even though it screens 100 stocks and avoids mega-cap tech entirely.
-
In terms of five-year total return, SCHD has seen 50%, which is less than SPY’s 79%. This gap largely attributes to a dividend review that doesn’t include leaders in AI technology.
-
A blend of DGRO, primarily featuring Apple, Microsoft, and Broadcom, and SCHD could effectively address the tech gap while still focusing on revenue.
-
Currently, analysts who predicted NVIDIA’s rise back in 2010 have identified their top 10 AI stocks, notably excluding the Schwab U.S. Dividend Stock ETF from the list.
A 63-year-old retiree with $400,000 is probably attracted to SCHD for its reliable income stream from its 100-stock screen. The top 10 stocks constitute a hefty 41% of the fund—meaning around $164,000 is tied up in those names. Given that SCHD manages about $94 billion, the concentration of assets warrants careful consideration before viewing it as a one-stop investment.
Strategy and Revenue Sources
SCHD tracks the Dow Jones U.S. Dividend 100 Index, focusing on companies with strong balance sheets and a history of increasing dividends for at least ten consecutive years. The revenue model is straightforward: dividends from mature, cash-generating firms are collected, and the index undergoes a yearly reconstitution every March. With a current yield of 3.27% and a minimal expense ratio of 0.06%, it stands out as one of the cost-effective options in this genre.
This screening process is particularly beneficial for retirees. For instance, Merck raised its quarterly dividend from $0.77 to $0.85 between 2024 and early 2026. Bristol-Myers Squibb made a small adjustment from $0.62 to $0.63 over the same timeframe. Such steady increases in dividend levels contribute to a stable income base for the fund.
Heavier Than the Peak S&P 500
The individual weights of the top 10 companies hover around 3%. Qualcomm leads the pack, followed by Texas Instruments, UnitedHealth, Chevron, Coca-Cola, ConocoPhillips, Verizon, and Amgen. Notably, while the S&P 500 top index is filled with mega-cap tech firms, the combined value of SCHD’s leading stocks exceeds the S&P’s 36% concentration among its top 10.
In a somewhat alarming note, sector-specific weight also complicates the picture. When the energy ratio was cut from 24% during the March 2026 reforms, it still remains close to 16%, bolstered by two significant oil players among the top five. The healthcare sector is around 18%, thanks to three pharmaceutical firms. The risk associated with a single stock in SCHD appears greater than what its 100-stock roster might imply.
Will It Be Delivered?
Over the past year, SCHD has returned 29%, outpacing SPY’s 27%, likely benefiting from a shift towards value stocks. However, expanding that timeline shows SCHD’s five-year total return at 50%, which is nearly 30 percentage points lower than SPY’s impressive 79%. This discrepancy reflects the cost incurred by SCHD investors opting out of the AI-driven bull market from 2023 to 2025. Even over a decade, SCHD’s performance remains at 233%, still trailing SPY’s 258%—though the gap is narrowing.
Trade Off
-
Concentration drift between reconstructions. March is essentially the reset month for weights. Those who acquired shares in October had different holdings compared to those who bought in April, as top stocks can shift significantly during that interval.
-
Sector circularity. Heavy allocations in energy and healthcare may result in the fund reacting more strongly to oil and drug pricing changes compared to broader indices.
-
Opportunity cost of growth. The dividend review process largely excludes many of the mega-cap tech stocks that have historically shed the most light on returns over the last decade in U.S. equity history.
Where Does the SCHD Fit and Pair?
SCHD serves as an income-centered core asset for retirees looking for yield and reliable quality at minimal costs. Given the significance of its top 10 holdings, it’s wise for investors to cap it at around 30% to 40% of their equity allocation. The Vanguard High Dividend Yield ETF, for instance, lists about 620 stocks with a top 10 concentration of nearly 24% and a five-year return of 69%. Similarly, the iShares Core Dividend Growth ETF showcases giants like Apple, Microsoft, and Broadcom, which would provide the tech coverage that SCHD lacks. Combining either of those with SCHD could help minimize single-stock risk while still pursuing the income goals that drew this retiree to the fund in the first place.
